StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)

Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%

Lifevantage pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lifevantage's pe ratio was 11.8× on Nov 11, 2026, against 8.9× a year earlier. Over the last 5 years it ranged from 5.3× to 100.0×, with a median of 16.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.8×+3.8
2025Dec 31, 20258.0×−46.8
2024Dec 31, 202454.8×+26.2
2023Dec 29, 202328.6×−64.4
2022Dec 30, 202293.0×+86.6
2021Dec 31, 20216.4×−4.6
2020Dec 31, 202011.1×−16.8
2019Dec 31, 201927.9×−4.3
2018Dec 31, 201832.2×−20.7
2017Dec 29, 201752.9×+33.9
2016Dec 30, 201619.0×−20.7
2015Dec 31, 201539.7×+28.4
2014Dec 31, 201411.2×−16.3
2013Dec 31, 201327.5×−3.8
2012Dec 31, 201231.3×–

More Lifevantage figures

See a number that looks wrong?